EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Employment, volunteering, and health‐related resource use in pre‐symptomatic AD: Results from the Anti‐Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) study

Carolyn W Zhu, Charlene Flournoy, Rema Raman, Mary Sano

Alzheimer's & Dementia · 2025

DOI: 10.1002/alz.70641 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Carolyn W Zhu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Employment, Volunteers. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, GHR Foundation, Eli Lilly.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Little is known about productive time use and health‐related resource use during “pre‐symptomatic” AD, defined by the presence of brain amyloid in the absence of cognitive symptoms. We compared changes in resource use and participation in paid employment and/or volunteering in cognitively unimpaired older adults with amyloid accumulation (Anti‐Amyloid Treatment in Asymptomatic Alzheimer's Disease [A4] study, N = 1165) to otherwise matched participants without amyloid accumulation (Longitudinal Evaluation of Amyloid Risk and Neurodegeneration [LEARN] study, N = 507). METHODS Health‐related resource use was self‐reported using the Resource Use Inventory (RUI). Longitudinal analyses examined effect on RUI from study (A4 vs LEARN), time, and their interaction, controlling for Alzheimer's Disease Cooperative Study‐Preclinical Alzheimer's Cognitive Composite (ADCS‐PACC) and the Clinical Dementia Rating (CDR) scale, and their change scores from baseline. RESULTS Over time, paid employment and volunteering decreased, and unpaid help and hospitalization increased. Results showed clear associations between ADCS‐PACC and CDR with RUI. DISCUSSION Little detectable impact of amyloid levels on RUI was found in pre‐symptomatic AD that has been identified as an ideal stage to target for dementia prevention. Highlights Using data from a cohort of cognitively unimpaired older adults with evidence of amyloid accumulation enrolled in the Anti‐Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) study and otherwise matched participants who did not meet subthreshold levels of amyloid accumulation enrolled in the Longitudinal Evaluation of Amyloid Risk and Neurodegeneration (LEARN) study, this study showed clear associations between clinical variables and resource use and participation in paid employment and volunteering but suggested little detectable impact of amyloid levels on rate of change during the preclinical stage. Our results suggest that economic benefits from currently available treatment that effectively removes amyloid may not be immediately or concurrently observed during the short timeline of clinical trials. It is critical that our examination of economic consequence of treatment include broad ranges of items on resource use and productivity loss, longer time horizon, and that we balance between cost of detection, treatment, and burden and benefit.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseEmploymentVolunteersHumansMaleFemaleAgedLongitudinal StudiesProdromal Symptoms

Stichwörter der Autor:innen

amyloiddementiaemploymenthealth‐related resourcespre‐symptomaticproductive time use

Autor:innen und Institutionen

  • Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Alzheimer Disease Research Center, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • James J Peters VA Medical Center, Bronx, New York, USA.
  • Alzheimer's Therapeutic Research Institute, University of Southern California, San Diego, California, USA.

Förderung

  • NIA NIH HHS
  • GHR Foundation
  • Eli Lilly
  • C.W.Z. and M.S. are also supported by the Department of Veterans Affairs, Veterans Health Administration
  • Alzheimer's Association
  • National Institute on Aging

Zitieren

APA

Zhu, C. W., Flournoy, C., Raman, R., & Sano, M. (2025). Employment, volunteering, and health‐related resource use in pre‐symptomatic AD: Results from the Anti‐Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) study. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70641

Vancouver

Zhu CW, Flournoy C, Raman R, Sano M. Employment, volunteering, and health‐related resource use in pre‐symptomatic AD: Results from the Anti‐Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) study. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70641

BibTeX
@article{Zhu2025,
  author = {Zhu, Carolyn W and Flournoy, Charlene and Raman, Rema and Sano, Mary},
  title = {Employment, volunteering, and health‐related resource use in pre‐symptomatic AD: Results from the Anti‐Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) study},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  doi = {10.1002/alz.70641}
}
Kostenlos starten →